全文获取类型
收费全文 | 6204篇 |
免费 | 464篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 276篇 |
妇产科学 | 71篇 |
基础医学 | 831篇 |
口腔科学 | 119篇 |
临床医学 | 749篇 |
内科学 | 1206篇 |
皮肤病学 | 133篇 |
神经病学 | 571篇 |
特种医学 | 544篇 |
外国民族医学 | 1篇 |
外科学 | 795篇 |
综合类 | 71篇 |
一般理论 | 2篇 |
预防医学 | 416篇 |
眼科学 | 117篇 |
药学 | 358篇 |
2篇 | |
中国医学 | 5篇 |
肿瘤学 | 404篇 |
出版年
2024年 | 15篇 |
2023年 | 80篇 |
2022年 | 115篇 |
2021年 | 253篇 |
2020年 | 158篇 |
2019年 | 226篇 |
2018年 | 269篇 |
2017年 | 192篇 |
2016年 | 191篇 |
2015年 | 235篇 |
2014年 | 285篇 |
2013年 | 323篇 |
2012年 | 400篇 |
2011年 | 391篇 |
2010年 | 280篇 |
2009年 | 242篇 |
2008年 | 278篇 |
2007年 | 297篇 |
2006年 | 229篇 |
2005年 | 172篇 |
2004年 | 152篇 |
2003年 | 105篇 |
2002年 | 104篇 |
2001年 | 55篇 |
2000年 | 50篇 |
1999年 | 45篇 |
1998年 | 140篇 |
1997年 | 167篇 |
1996年 | 141篇 |
1995年 | 118篇 |
1994年 | 121篇 |
1993年 | 102篇 |
1992年 | 52篇 |
1991年 | 66篇 |
1990年 | 54篇 |
1989年 | 70篇 |
1988年 | 68篇 |
1987年 | 58篇 |
1986年 | 66篇 |
1985年 | 70篇 |
1984年 | 44篇 |
1983年 | 30篇 |
1982年 | 37篇 |
1981年 | 41篇 |
1980年 | 28篇 |
1979年 | 13篇 |
1978年 | 13篇 |
1977年 | 21篇 |
1976年 | 28篇 |
1975年 | 19篇 |
排序方式: 共有6751条查询结果,搜索用时 9 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
3.
4.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
5.
6.
7.
8.
9.
This study looked at the prevalence of panic attacks and panic disorder in a British population. Three thousand people (aged 18-65) registered with a Leicester general practice were sent a postal questionnaire which screened for panic attacks. Where appropriate this was followed by a diagnostic interview. Preliminary results are reported for the first 1500 subjects sampled. Panic attacks are a common experience in the study population (7.5% of responders experienced them around the time of the interview). Panic disorder was diagnosed in about 3% of responders. 相似文献
10.
A A Abitbol J G Schwade A A Lewin K Sridhar A H Brandon A M Markoe R R Casiano P V Houdek C Serago D J Miller 《American journal of clinical oncology》1992,15(3):250-255
Seventeen patients were entered into a Phase I/II trial of concurrent hyperfractionated radiation therapy (7,440 cGy total dose; 120 cGy b.i.d.) combined with constant infusion of 5-fluorouracil (5-FU) (1,000 mg/m2/24 hours for 72 hours) and cisplatin (DDP) (50 mg/m2) for a total of three cycles. Thirteen patients had Stage IV disease; three, Stage III disease; and one, Stage II hypopharyngeal disease. Thirteen of 17 patients had positive cervical lymph nodes, and the mean size of the largest lymph node was 5.5 x 5.1 cm. The patients were not treated with planned adjunctive surgery except for one patient who had a radical neck dissection for massive, rapidly growing cervical adenopathy, which recurred promptly within 1 month before the initiation of protocol therapy. After the initial six patients were entered, mitomycin-C (Mito 8 mg/m2) was added during the second cycle. All the patients completed the planned course of radiotherapy with a median dose of 7,440 cGy and a mean dose of 7,248 cGy except for two patients who died--one from toxicity and the other, suicide. The predominant toxicity was mucositis, which was grade 3/4 in 11 of 15 patients, resulting in an average interruption of radiation therapy of 12 days. Weight loss was significant and was on the average 12% of baseline weight. Hematological toxicity was mild in the 5-FU/DDP group (only one grade 3 toxicity of six) and severe in the 5-FU/DDP/Mito-treated patients (five of eight patients having grade 3/4 toxicity including one leukopenic pneumonitis death). Additional toxicity included one parapharyngeal cellulitis, which responded to antibiotics. Noncompliance with the complex regimen was only seen in three patients. One patient refused b.i.d. radiation therapy, and one patient refused further chemotherapy after the first cycle. Additionally, one patient who had a severe ethanol withdrawal reaction during the first cycle of 5-FU/DDP did not receive further chemotherapy. The complete response rate of both primary site and neck by the protocol regimen alone was 71%. However, two patients, one from each group, did undergo salvage neck dissection, and the locoregional control is currently 73%, with a mean follow-up time of 18.4 months. The feasibility of combining hyperfractionated radiation therapy with aggressive concurrent chemotherapy was demonstrated. The response and local control rate justifies the added toxicity of concurrent chemotherapy and radiation therapy. 相似文献